Biocept Company Profile (NASDAQ:BIOC)

About Biocept

Biocept logoBiocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.60
  • 50 Day Moving Average: $0.6206
  • 200 Day Moving Average: $0.9505
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.11
  • P/E Growth: -0.0200
  • Market Cap: $14.94M
  • Outstanding Shares: 25,189,000
  • Beta: 2.03
Additional Links:
Companies Related to Biocept:

Analyst Ratings

Consensus Ratings for Biocept (NASDAQ:BIOC) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.07 (411.03% upside)

Analysts' Ratings History for Biocept (NASDAQ:BIOC)
Show:
DateFirmActionRatingPrice TargetDetails
8/3/2016Feltl & Co.DowngradeBuy -> HoldView Rating Details
6/6/2016Roth CapitalInitiated CoverageBuy$1.20View Rating Details
5/24/2016Rodman & RenshawReiterated RatingBuyView Rating Details
1/10/2016HC WainwrightReiterated RatingBuy$4.00View Rating Details
1/21/2015AegisReiterated RatingBuyView Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Biocept (NASDAQ:BIOC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/2/2016Q216($0.22)($0.20)ViewN/AView Earnings Details
5/12/2016Q116($0.23)($0.25)ViewListenView Earnings Details
3/9/2016Q415($0.26)($0.24)$76.00 million$218.00 millionViewN/AView Earnings Details
11/5/2015Q315($0.22)($0.24)$165.00 millionViewN/AView Earnings Details
8/10/2015Q215($0.23)($0.22)$19.25 million$76.77 millionViewListenView Earnings Details
5/12/2015Q115($0.61)($0.37)ViewListenView Earnings Details
3/9/2015Q414($0.88)($0.87)ViewN/AView Earnings Details
11/13/2014($0.82)($0.87)ViewN/AView Earnings Details
8/15/2014($0.67)($0.67)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biocept (NASDAQ:BIOC)
Current Year EPS Consensus Estimate: $-0.81 EPS
Next Year EPS Consensus Estimate: $-0.54 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.22)($0.22)($0.22)
Q3 20162($0.22)($0.18)($0.20)
Q4 20162($0.20)($0.18)($0.19)
Q1 20171($0.20)($0.20)($0.20)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.18)($0.18)($0.18)
Q4 20171($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Biocept (NASDAQ:BIOC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biocept (NASDAQ:BIOC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2016Bruce GerhardtDirectorBuy25,000$1.00$25,000.00View SEC Filing  
5/4/2016Claire ReissMajor ShareholderBuy614,273$1.00$614,273.00View SEC Filing  
2/13/2015David F HaleChairmanBuy40,000$1.25$50,000.00View SEC Filing  
2/13/2015Marsha Alpert ChandlerDirectorBuy2,000$1.25$2,500.00View SEC Filing  
2/13/2015Michael W NallCEOBuy12,000$1.25$15,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biocept (NASDAQ:BIOC)
DateHeadline
News IconStock's Buzz: Biocept, Inc. (NASDAQ:BIOC), NorthStar Asset Management Group, Inc. (NYSE:NSAM) - Newburg Press (NASDAQ:BIOC)
newburghpress.com - August 24 at 3:50 PM
News IconStocks Trapped in Bearish Claws: EnteroMedics Inc. (NASDAQ:ETRM), Biocept, Inc. (NASDAQ:BIOC) - Street Wise Report (press release) (blog) (NASDAQ:BIOC)
streetwisereport.com - August 24 at 12:04 PM
capitalcube.com logoETF’s with exposure to Biocept, Inc. : August 23, 2016 (NASDAQ:BIOC)
www.capitalcube.com - August 23 at 3:52 PM
investornewswire.com logoWill Biocept, Inc. (NASDAQ:BIOC) Hit $2.5 Price Target? - Investor Newswire (NASDAQ:BIOC)
www.investornewswire.com - August 21 at 8:33 AM
publicnow.com logoBiocept to Present at Next Generation Dx Summit (NASDAQ:BIOC)
www.publicnow.com - August 18 at 12:15 PM
sbwire.com logoReport Published: "Liquid Biopsy Market - Forecast to 2021" (NASDAQ:BIOC)
www.sbwire.com - August 17 at 12:02 PM
finance.yahoo.com logoBIOCEPT INC Financials (NASDAQ:BIOC)
finance.yahoo.com - August 13 at 3:50 PM
capitalcube.com logoETF’s with exposure to Biocept, Inc. : August 12, 2016 (NASDAQ:BIOC)
www.capitalcube.com - August 12 at 4:03 PM
News IconBiocept Inc. Signs Distribution Deal for Philippines (NASDAQ:BIOC)
sdbj.com - August 11 at 9:43 PM
reuters.com logoBRIEF-Biocept expands distribution of liquid biopsy tests to Philippines (NASDAQ:BIOC)
www.reuters.com - August 11 at 12:00 PM
publicnow.com logoBiocept Expands Distribution of Liquid Biopsy Tests to the Philippines (NASDAQ:BIOC)
www.publicnow.com - August 11 at 11:59 AM
capitalcube.com logoBiocept, Inc. :BIOC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:BIOC)
www.capitalcube.com - August 9 at 4:57 PM
biz.yahoo.com logoBIOCEPT INC Files SEC form 10-Q, Quarterly Report (NASDAQ:BIOC)
biz.yahoo.com - August 5 at 9:13 PM
News IconSan Diego Entrepreneurs Launch Innovative E-Commerce Health Care Company (NASDAQ:BIOC)
cad.digitalmedianet.com - August 4 at 3:57 PM
twst.com logoBiocept Inc.: Biocept Reports 2016 Second Quarter Financial Results (NASDAQ:BIOC)
www.twst.com - August 3 at 9:31 PM
fortune.com logoAnalyst Ratings On Watch List: Biocept Inc (NASDAQ:BIOC ... - Review Fortune (NASDAQ:BIOC)
reviewfortune.com - August 3 at 3:53 PM
News IconAnalyst Overview: Biocept, Inc. (NASDAQ:BIOC) - News Oracle (NASDAQ:BIOC)
www.newsoracle.com - August 3 at 12:30 PM
biz.yahoo.com logoBIOCEPT INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:BIOC)
biz.yahoo.com - August 3 at 12:30 PM
twst.com logoBiocept Inc.: Biocept Reports 2016 Second Quarter Financial Results - The Wall Street Transcript (NASDAQ:BIOC)
www.twst.com - August 2 at 3:53 PM
publicnow.com logoBiocept Reports 2016 Second Quarter Financial Results (NASDAQ:BIOC)
www.publicnow.com - August 2 at 8:38 AM
biz.yahoo.com logoBIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:BIOC)
biz.yahoo.com - August 2 at 8:38 AM
sg.finance.yahoo.com logoGSK, Google parent company to make bioelectronic medicine (NASDAQ:BIOC)
sg.finance.yahoo.com - August 1 at 4:18 AM
News IconBiocept names Timothy Kennedy as CFO and SVP of operations (NASDAQ:BIOC)
www.poandpo.com - July 29 at 9:18 PM
4-traders.com logoBiocept : Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations (NASDAQ:BIOC)
www.4-traders.com - July 29 at 9:18 PM
twst.com logoBiocept Inc.: Biocept Appoints Timothy C. Kennedy as Chief ... - The Wall Street Transcript (NASDAQ:BIOC)
www.twst.com - July 27 at 9:36 PM
einnews.com logoGlobal Circulating Tumor Cells Market 2015 Analysis and Forecast to 2022 (NASDAQ:BIOC)
www.einnews.com - July 27 at 12:20 PM
publicnow.com logoBiocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations (NASDAQ:BIOC)
www.publicnow.com - July 27 at 8:18 AM
biz.yahoo.com logoBIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:BIOC)
biz.yahoo.com - July 27 at 8:11 AM
finance.yahoo.com logo8:10 am Biocept names Timothy C. Kennedy as CFO effective immediately (NASDAQ:BIOC)
finance.yahoo.com - July 27 at 8:10 AM
twst.com logoBiocept Inc.: Biocept to Release Second Quarter Financial Results on August 2, 2016 and Host Investor Conference ... - The Wall Street Transcript (NASDAQ:BIOC)
www.twst.com - July 26 at 3:41 PM
News IconHC Stocks Judgment: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Biocept Inc (NASDAQ:BIOC) - share market updates (press release) (NASDAQ:BIOC)
sharemarketupdates.com - July 26 at 3:41 PM
publicnow.com logoBiocept to Release Second Quarter Financial Results on August 2, 2016 and Host Investor Conference Call at 11:00 a.m. Eastern Time (NASDAQ:BIOC)
www.publicnow.com - July 25 at 8:18 AM
investornewswire.com logoIs $2.5 Price Target Attainable For Biocept, Inc. (NASDAQ:BIOC)? - Investor Newswire (NASDAQ:BIOC)
www.investornewswire.com - July 23 at 8:04 AM
capitalcube.com logoETF’s with exposure to Biocept, Inc. : July 21, 2016 (NASDAQ:BIOC)
www.capitalcube.com - July 21 at 1:49 PM
finance.yahoo.com logoLiquid Biopsy Market Worth 1.66 Billion USD by 2021 (NASDAQ:BIOC)
finance.yahoo.com - July 21 at 12:20 PM
capitalcube.com logoGlaxoSmithKline (Egypt) : Neutral outlook but great fundamentals (NASDAQ:BIOC)
www.capitalcube.com - July 20 at 4:10 PM
capitalcube.com logoGlaxoSmithKline (Egypt): Price momentum supported by strong fundamentals (NASDAQ:BIOC)
www.capitalcube.com - July 19 at 4:20 PM
investornewswire.com logoStrong Sell Calls For Biocept, Inc. (NASDAQ:BIOC) At 0 - Investor Newswire (NASDAQ:BIOC)
www.investornewswire.com - July 16 at 9:25 AM
ftsenews.co.uk logoNew Broker Ratings For Biocept, Inc. (BIOC) - FTSE News (NASDAQ:BIOC)
www.ftsenews.co.uk - July 15 at 2:24 PM
News IconHC Stocks Buzzer: Biocept Inc (NASDAQ:BIOC), CytRx Corporation (NASDAQ:CYTR) - share market updates (press release) (NASDAQ:BIOC)
sharemarketupdates.com - July 13 at 3:49 PM
News IconHC Stocks Review: Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), Biocept Inc (NASDAQ:BIOC) - share market updates (press release) (NASDAQ:BIOC)
sharemarketupdates.com - July 12 at 9:18 PM
investornewswire.com logoIs $2.5 Within Reach For Biocept, Inc. (NASDAQ:BIOC)? - Investor Newswire (NASDAQ:BIOC)
www.investornewswire.com - July 8 at 8:55 PM
4-traders.com logoBIOCEPT INC : Change in Directors or Principal Officers (form 8-K) (NASDAQ:BIOC)
www.4-traders.com - July 7 at 9:04 PM
biz.yahoo.com logoBIOCEPT INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:BIOC)
biz.yahoo.com - July 7 at 4:30 PM
News IconGlobal Circulating Tumor Cells (CTC) Technologies Market 2016 – ANGLE plc, Biocept Inc., Abnova Corporation ... - Patriarc (NASDAQ:BIOC)
patriarc.com - July 5 at 3:50 PM
finance.yahoo.com logoBiocept Gets Japanese Patent Covering Microchannel And Antibody Capture (NASDAQ:BIOC)
finance.yahoo.com - July 5 at 9:59 AM
publicnow.com logoBiocept Granted Japanese Patent Covering Microchannel and Antibody Capture (NASDAQ:BIOC)
www.publicnow.com - July 5 at 7:11 AM
fiscalstandard.com logoBiocept, Inc. (BIOC) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:BIOC)
www.fiscalstandard.com - July 4 at 3:46 PM
investornewswire.com logoBiocept, Inc. (NASDAQ:BIOC) Expected to Reach Highs Of $2.5 - Investor Newswire (NASDAQ:BIOC)
www.investornewswire.com - July 2 at 11:29 AM
4-traders.com logoBIOCEPT INC : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:BIOC)
www.4-traders.com - June 29 at 8:56 PM

Social

Biocept (NASDAQ:BIOC) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff